Zacks Research Issues Optimistic Forecast for PAHC Earnings

Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) - Analysts at Zacks Research increased their Q1 2026 earnings per share (EPS) estimates for Phibro Animal Health in a report issued on Wednesday, June 18th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.32 for the quarter, up from their previous forecast of $0.31. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q2 2026 earnings at $0.59 EPS, Q3 2026 earnings at $0.60 EPS, FY2026 earnings at $2.18 EPS, Q1 2027 earnings at $0.54 EPS and Q2 2027 earnings at $0.58 EPS.

Several other research analysts have also commented on the company. BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target for the company in a research report on Monday. BNP Paribas upgraded Phibro Animal Health to a "hold" rating in a research report on Monday. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $20.80.

Phibro Animal Health Trading Down 2.0%

PAHC opened at $23.96 on Thursday. Phibro Animal Health has a 52 week low of $16.16 and a 52 week high of $26.55. The business has a fifty day simple moving average of $21.49 and a 200-day simple moving average of $21.91. The firm has a market cap of $971.10 million, a P/E ratio of 30.72, a P/E/G ratio of 0.46 and a beta of 0.74. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. The company had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%.

Institutional Investors Weigh In On Phibro Animal Health

Several institutional investors have recently modified their holdings of PAHC. Nuveen LLC purchased a new stake in Phibro Animal Health in the 1st quarter valued at approximately $10,312,000. Invesco Ltd. lifted its stake in Phibro Animal Health by 92.3% in the 1st quarter. Invesco Ltd. now owns 387,739 shares of the company's stock valued at $8,282,000 after buying an additional 186,087 shares in the last quarter. Axecap Investments LLC purchased a new stake in Phibro Animal Health in the 1st quarter valued at approximately $3,696,000. Millennium Management LLC lifted its stake in Phibro Animal Health by 74.3% in the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company's stock valued at $7,733,000 after buying an additional 154,281 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its stake in Phibro Animal Health by 56.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock valued at $6,325,000 after buying an additional 108,918 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.00%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.